vs
California Resources Corp（CRC）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
California Resources Corp的季度营收约是RIGEL PHARMACEUTICALS INC的1.7倍（$119.0M vs $69.8M），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs -46.3%）
加州资源集团是一家美国能源企业，主要在加州开展油气勘探业务。公司注册地为特拉华州，总部位于加州长滩，所持有的加州矿产地块面积是该州私有主体中的最高水平。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
CRC vs RIGL — 直观对比
营收规模更大
CRC
是对方的1.7倍
$69.8M
两年增速更快
RIGL
近两年复合增速
-46.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $119.0M | $69.8M |
| 净利润 | — | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | -597.5% | 33.2% |
| 净利率 | — | 384.0% |
| 营收同比 | — | 21.2% |
| 净利润同比 | — | 1769.2% |
| 每股收益（稀释后） | $-8.02 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CRCRIGL
| Q1 26 | $119.0M | — | ||
| Q4 25 | $679.0M | $69.8M | ||
| Q3 25 | $715.0M | $69.5M | ||
| Q2 25 | $702.0M | $101.7M | ||
| Q1 25 | $814.0M | $53.3M | ||
| Q4 24 | $826.0M | $57.6M | ||
| Q3 24 | $870.0M | $55.3M | ||
| Q2 24 | $412.0M | $36.8M |
净利润CRCRIGL
| Q1 26 | — | — | ||
| Q4 25 | $12.0M | $268.1M | ||
| Q3 25 | $64.0M | $27.9M | ||
| Q2 25 | $172.0M | $59.6M | ||
| Q1 25 | $115.0M | $11.4M | ||
| Q4 24 | $33.0M | $14.3M | ||
| Q3 24 | $345.0M | $12.4M | ||
| Q2 24 | $8.0M | $-1.0M |
毛利率CRCRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% |
营业利润率CRCRIGL
| Q1 26 | -597.5% | — | ||
| Q4 25 | 6.9% | 33.2% | ||
| Q3 25 | 13.7% | 40.9% | ||
| Q2 25 | 38.0% | 60.1% | ||
| Q1 25 | 22.9% | 23.9% | ||
| Q4 24 | 8.2% | 28.9% | ||
| Q3 24 | 59.5% | 25.4% | ||
| Q2 24 | 9.2% | 1.2% |
净利率CRCRIGL
| Q1 26 | — | — | ||
| Q4 25 | 1.8% | 384.0% | ||
| Q3 25 | 9.0% | 40.2% | ||
| Q2 25 | 24.5% | 58.6% | ||
| Q1 25 | 14.1% | 21.5% | ||
| Q4 24 | 4.0% | 24.9% | ||
| Q3 24 | 39.7% | 22.5% | ||
| Q2 24 | 1.9% | -2.8% |
每股收益（稀释后）CRCRIGL
| Q1 26 | $-8.02 | — | ||
| Q4 25 | $0.21 | $14.11 | ||
| Q3 25 | $0.76 | $1.46 | ||
| Q2 25 | $1.92 | $3.28 | ||
| Q1 25 | $1.26 | $0.63 | ||
| Q4 24 | $0.87 | $0.82 | ||
| Q3 24 | $3.78 | $0.70 | ||
| Q2 24 | $0.11 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $2.9B | $391.5M |
| 总资产 | — | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资CRCRIGL
| Q1 26 | — | — | ||
| Q4 25 | $132.0M | $155.0M | ||
| Q3 25 | $196.0M | $137.1M | ||
| Q2 25 | $72.0M | $108.4M | ||
| Q1 25 | $214.0M | $77.1M | ||
| Q4 24 | $372.0M | $77.3M | ||
| Q3 24 | $241.0M | $61.1M | ||
| Q2 24 | $1.0B | $49.1M |
总债务CRCRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | $52.5M | ||
| Q3 25 | $1.0B | $60.0M | ||
| Q2 25 | $1.0B | $60.0M | ||
| Q1 25 | $1.0B | $60.0M | ||
| Q4 24 | $1.1B | $60.0M | ||
| Q3 24 | $1.1B | $60.0M | ||
| Q2 24 | $1.2B | $60.0M |
股东权益CRCRIGL
| Q1 26 | $2.9B | — | ||
| Q4 25 | $3.7B | $391.5M | ||
| Q3 25 | $3.4B | $117.6M | ||
| Q2 25 | $3.4B | $81.9M | ||
| Q1 25 | $3.5B | $18.6M | ||
| Q4 24 | $3.5B | $3.3M | ||
| Q3 24 | $3.5B | $-14.6M | ||
| Q2 24 | $2.1B | $-29.9M |
总资产CRCRIGL
| Q1 26 | — | — | ||
| Q4 25 | $7.4B | $513.6M | ||
| Q3 25 | $6.8B | $242.5M | ||
| Q2 25 | $6.7B | $206.7M | ||
| Q1 25 | $6.8B | $176.0M | ||
| Q4 24 | $7.1B | $164.0M | ||
| Q3 24 | $7.1B | $139.4M | ||
| Q2 24 | $4.5B | $128.4M |
负债/权益比CRCRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | 0.13× | ||
| Q3 25 | 0.29× | 0.51× | ||
| Q2 25 | 0.30× | 0.73× | ||
| Q1 25 | 0.29× | 3.23× | ||
| Q4 24 | 0.32× | 18.25× | ||
| Q3 24 | 0.32× | — | ||
| Q2 24 | 0.57× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $99.0M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $-32.0M | — |
| 自由现金流率自由现金流/营收 | -26.9% | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $380.0M | — |
8季度趋势，按日历期对齐
经营现金流CRCRIGL
| Q1 26 | $99.0M | — | ||
| Q4 25 | $235.0M | $22.0M | ||
| Q3 25 | $279.0M | $24.0M | ||
| Q2 25 | $165.0M | $30.5M | ||
| Q1 25 | $186.0M | $-893.0K | ||
| Q4 24 | $206.0M | $14.5M | ||
| Q3 24 | $220.0M | $21.7M | ||
| Q2 24 | $97.0M | $302.0K |
自由现金流CRCRIGL
| Q1 26 | $-32.0M | — | ||
| Q4 25 | $115.0M | — | ||
| Q3 25 | $188.0M | — | ||
| Q2 25 | $109.0M | — | ||
| Q1 25 | $131.0M | — | ||
| Q4 24 | $118.0M | — | ||
| Q3 24 | $141.0M | — | ||
| Q2 24 | $63.0M | — |
自由现金流率CRCRIGL
| Q1 26 | -26.9% | — | ||
| Q4 25 | 16.9% | — | ||
| Q3 25 | 26.3% | — | ||
| Q2 25 | 15.5% | — | ||
| Q1 25 | 16.1% | — | ||
| Q4 24 | 14.3% | — | ||
| Q3 24 | 16.2% | — | ||
| Q2 24 | 15.3% | — |
资本支出强度CRCRIGL
| Q1 26 | — | — | ||
| Q4 25 | 17.7% | — | ||
| Q3 25 | 12.7% | — | ||
| Q2 25 | 8.0% | — | ||
| Q1 25 | 6.8% | — | ||
| Q4 24 | 10.7% | — | ||
| Q3 24 | 9.1% | — | ||
| Q2 24 | 8.3% | — |
现金转化率CRCRIGL
| Q1 26 | — | — | ||
| Q4 25 | 19.58× | 0.08× | ||
| Q3 25 | 4.36× | 0.86× | ||
| Q2 25 | 0.96× | 0.51× | ||
| Q1 25 | 1.62× | -0.08× | ||
| Q4 24 | 6.24× | 1.01× | ||
| Q3 24 | 0.64× | 1.75× | ||
| Q2 24 | 12.13× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
